What is the probability that higher versus lower quality of evidence represents true effects estimates?
Djulbegovic B. et al, (2024), Journal of Evaluation in Clinical Practice
Ten resources for understanding bias in health research: EBM live workshop 2022.
Nunan D. et al, (2023), BMJ Evid Based Med
Clinical trials of pharmacological interventions for SARS-CoV-2 published in leading medical journals report adherence but not how it was assessed
Lee C. et al, (2023), British Journal of Clinical Pharmacology
Insights into the quantification and reporting of model-related uncertainty across different disciplines
Simmonds EG. et al, (2022), iScience, 25
'Delicate diagnosis': avoiding harms in difficult, disputed, and desired diagnoses
McCartney M. et al, (2022), British Journal of General Practice, 72, 580 - 581
Open science and conflict of interest policies of medical and health sciences journals before and during the COVID-19 pandemic: A repeat cross-sectional study
Gardener AD. et al, (2022), JRSM Open, 13, 205427042211321 - 205427042211321
Appraising qualitative health research—towards a differentiated approach
Williams V. et al, (2022), BMJ Evidence-Based Medicine, 27, 212 - 214
Physical activity for treatment of irritable bowel syndrome
Nunan D. et al, (2022), Cochrane Database of Systematic Reviews, 2022
Incidence of Sudden Cardiac Arrest and Death in Young Athletes and Military Members: A Systematic Review and Meta-Analysis
Lear A. et al, (2022), Journal of Athletic Training, 57, 431 - 443
Screening Electrocardiogram in Young Athletes and Military Members: A Systematic Review and Meta-Analysis
Lear A. et al, (2022), Journal of Athletic Training, 57, 444 - 451
Advocating for evidence-informed decisions to make healthcare fit for each person
Franco JVA. et al, (2022), BMJ evidence-based medicine, 27, 65 - 66
High quality (certainty) evidence changes less often than low-quality evidence, but the magnitude of effect size does not systematically differ between studies with low versus high-quality evidence
Djulbegovic B. et al, (2022), Journal of Evaluation in Clinical Practice
Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
Haber NA. et al, (2021), Trials, 22
The REPRISE project: protocol for an evaluation of REProducibility and Replicability In Syntheses of Evidence
Page MJ. et al, (2021), Systematic Reviews, 10